Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MC240701 Decentralized Pilot Study of Triple Oral Metronomic Chemotherapy for Patients With Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population

NCT06997068 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT06997068
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06997068 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MC240701 Decentralized Pilot Study of Triple Oral Metronomic Chemotherapy for Patients With Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Recruiting
Start date
August 7, 2025
Completion date
August 5, 2029
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clinical stage iv hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8, head and neck cancer, hypopharynx cancer, metastatic hypopharyngeal carcinoma, metastatic laryngeal carcinoma, metastatic malignant head and neck neoplasm, metastatic oral cavity carcinoma, metastatic oropharyngeal carcinoma, oropharynx cancer, recurrent hypopharyngeal carcinoma, recurrent laryngeal carcinoma, recurrent malignant head and neck neoplasm, recurrent oral cavity carcinoma, recurrent oropharyngeal carcinoma, stage ivc hypopharyngeal carcinoma ajcc v8, stage ivc laryngeal cancer ajcc v8, stage ivc lip and oral cavity cancer ajcc v8, stage ivc oropharyngeal (p16-negative) carcinoma ajcc v8